Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.
Transform life sciences with AI-driven data strategies for impactful insights across the product lifecycle.
Learn about our data strategy and analytics services for pharmaceutical companies in the life science industry.
Mobile navigation menu modal
Explore our latest insights and perspectives in these life science resources, news articles, and events.
Explore how AI is reshaping Medical Affairs, driving precision, enhancing patient outcomes, and unlocking new opportunities for biopharma in 2025
Explore a new model for antibiotic investment—driven by AMR, evolving P&R frameworks, and key indicators shaping commercial strategy.
Refined HCP targeting in rare disease using integrated data, boosting hit rates from 10% to 50% and delivering 3x ROI in 6 months.
Used GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
Future-proofed data strategy with Putnam: gaps identified, vendors vetted, leading to a first US multi-source tokenized DB.
Built a data gateway aligning insights with market realities to map complex patient journeys and power ML-driven HCP engagement.
Built a first in US data platform combining claims data, improving patient coverage by 30% and enriching insights.
Explore how CMS set 2024 drug MFPs under the IRA—insights, data drivers & pharma strategies for future Medicare negotiations.
CAR-T innovation in solid tumors shows mixed results at ASCO® 2025, progress seen, but safety, delivery & durability challenges remain.
Discover how AI & claims data are transforming Medical Affairs in this MAPS webinar with experts from Putnam, Genentech & more.
Explore how MAPS EMEA 2025 redefined Medical Affairs - patient-centricity, AI, evidence generation & launch excellence take center stage
Explore the latest executive order on drug pricing, focusing on IRA pill penalty reform, its implications for Medicare savings, and pharma market..
Looking to get in touch with an expert or team member?
Tell us how we can help.
